Oxyntomodulin augments glucose homeostasis

March 21, 2018

(HealthDay)—In obese subjects with and without type 2 diabetes mellitus (T2DM), oxyntomodulin (OXM) significantly augments glucose-dependent insulin secretion, according to a study published online March 15 in Diabetes.

Sudha S. Shankar, M.D., from Merck & Co. Inc. in Kenilworth, N.J., and colleagues examined the effects of OXM on glucose homeostasis. The effects of an intravenous infusion of native OXM on insulin secretory rates (ISR) and glycemic excursion were assessed in a graded glucose infusion (GGI) procedure in two separate placebo-controlled trials in 12 overweight and obese subjects without and in 12 obese subjects with T2DM. The glucagon-like peptide-1 (GLP-1) analog liraglutide was a comparator in the T2DM trial.

The researchers found that in the GGI, 3.0 pmol/kg/min of OXM significantly increased ISR in both groups and blunted glycemic excursion relative to placebo. The effects of OXM were comparable to those of liraglutide among individuals with T2DM, including the restoration of beta cell glucose responsiveness to that of non-obese subjects without diabetes.

"Our findings indicate that native OXM significantly augments glucose-dependent insulin secretion acutely in obese subjects with and without diabetes, with effects comparable to pharmacologic GLP-1 receptor activation and independent of ," the authors write. "Native OXM has potential to improve hyperglycemia via complementary and independent induction of secretion and weight loss."

Several authors disclosed financial ties to Merck Sharp & Dohme Corp., a subsidiary of Merck & Co. Inc.

Explore further: Beta-cell sensitivity to glucose impaired after gastric bypass

More information: Abstract/Full Text (subscription or payment may be required)

Related Stories

Beta-cell sensitivity to glucose impaired after gastric bypass

December 11, 2017
(HealthDay)—Individuals with prior Roux-en-Y gastric bypass (GB) have blunted β-cell sensitivity to changes in glycemia, according to a study published online Nov. 20 in Diabetes, Obesity and Metabolism.

DPP-4 inhibitor has dissociated effects on β-cell function

December 20, 2017
(HealthDay)—For healthy adults and individuals with well-controlled type 2 diabetes (T2D), a single dose of the dipeptidyl peptidase-4 inhibitor sitagliptin is associated with increased standardized insulin secretion, with ...

Brain glucose responses diminish with diabetes, obesity

November 20, 2017
(HealthDay)—The rise of brain glucose levels is blunted during hyperglycemia in adults with obesity and type 2 diabetes mellitus (T2DM), according to a study published online Oct. 19 in JCI Insight.

Absolute incretin effect reduced in type 2 diabetes

June 25, 2012
(HealthDay) -- For patients with type 2 diabetes mellitus (T2DM) the absolute incretin effect is reduced compared with healthy individuals, but its relative importance is increased, particularly in first-phase insulin secretion, ...

Pre-op liraglutide cuts post-op plasma glucose in T2DM

December 19, 2017
(HealthDay)—For patients with type 2 diabetes mellitus undergoing non-cardiac surgery, premedication with liraglutide is associated with reduced median plasma glucose one hour postoperatively, according to a study published ...

Adipose tissue insulin resistance up in obese-NGT, IGT, T2DM

January 9, 2017
(HealthDay)—Resistance to the antilipolytic effect of insulin (Adipo-IR) is increased in obese individuals with normal glucose tolerance (NGT), and in those with impaired glucose tolerance (IGT) and type 2 diabetes (T2DM), ...

Recommended for you

Genomic study brings us closer to precision medicine for type 2 diabetes

September 21, 2018
Most patients diagnosed with type 2 diabetes are treated with a "one-size-fits-all" protocol that is not tailored to each person's physiology and may leave many cases inadequately managed. A new study by scientists at the ...

High gluten diet in pregnancy linked to increased risk of diabetes in children

September 19, 2018
A high gluten intake by mothers during pregnancy is associated with an increased risk of their child developing type 1 diabetes, suggests a study published by The BMJ today.

Anti-inflammatory protein promotes healthy gut bacteria to curb obesity

September 19, 2018
Scientists from the UNC School of Medicine discovered that the anti-inflammatory protein NLRP12 normally helps protect mice against obesity and insulin resistance when they are fed a high-fat diet. The researchers also reported ...

Study reveals the current rates of diagnosed type 1 and type 2 diabetes in American adults

September 18, 2018
A new study from the University of Iowa finds that type 2 diabetes remains overwhelmingly the most common type of diabetes diagnosed in American adults who have the disease.

Research reveals link between immunity, diabetes

September 14, 2018
When it comes to diet-induced obesity, your immune system is not always your friend.

BPA exposure in U.S.-approved levels may alter insulin response in non-diabetic adults

September 14, 2018
In a first study of its kind study, researchers have found that a common chemical consumers are exposed to several times a day may be altering insulin release. Results of the study, led by scientists at the University of ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.